Neupro improves motor, sleep, non-motor symptoms of PD in Recover study: UCB
UCB claims that the Recover study is the first large-scale trial to investigate early morning motor function and sleep as coprimary outcome measures in Parkinson’s disease (PD). Data
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.